Alterola Biotech Inc (OTCMKTS:ALTA) Director Jr. Fred W. Fairclough sold 3,750 shares of the business’s stock in a transaction dated Wednesday, July 29th. The shares were sold at an average price of $20.26, for a total value of $75,975.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Shares of ALTA stock opened at $20.42 on Friday. The company has a 50-day moving average of $12.30. Alterola Biotech Inc has a 52-week low of $13.55 and a 52-week high of $31.27.

Alterola Biotech (OTCMKTS:ALTA) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $0.55 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.47 by $0.08.

About Alterola Biotech

Alterola Biotech, Inc, a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Its products under development include appetite suppressors, cholesterol suppressors, antioxidant gums, motion sickness suppressors, and vitamin gums.

Recommended Story: What is Liquidity?

Receive News & Ratings for Alterola Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alterola Biotech and related companies with MarketBeat.com's FREE daily email newsletter.